About this episode

Lynn Hamilton interviews Carol Aliyar about the evolution of pharmacovigilance into a strategic, technology-driven discipline.

In this episode of the Functionally Speaking series, host Lynn Hamilton speaks with Carol Aliyar, Executive Vice President and Global Head of Safety and Pharmacovigilance (PV) at Syneos Health, about the transformation of PV from a highly regulated, task-oriented function into a more strategic and technology-enabled discipline. With over 30 years in the industry and a career that spans commercial, clinical and safety roles, Carol brings a rare full-spectrum perspective. Listeners will ...

People in this episode

Host: Lynn Hamilton

Guest: Carol Aliyar

Topics covered

• Safety
• Pharmacovigilance
• Technology
• Regulation
• Industry Transformation

Keywords

• pharmacovigilance
• safety
• technology
• regulation
• industry transformation

Mentioned in this episode

Organizations: Syneos Health

More episodes of The Syneos Health Podcast

• Site Realities Series | Navigating Complexity: Communication, Escalation Paths and Site Partnership at Scale · May 29, 2026 · 16 min
• Site Realities Series | Building Trust at the Site Level: The CRA as Ambassador and Partner · May 22, 2026 · 25 min
• Introducing: Conversations on Commercialization · May 11, 2026 · 1 min
• Site Realities Series | From Monitor to Strategic Partner: The Evolution of the CRA Role · May 11, 2026 · 25 min
• Conversations on Commercialization: Navigating Dermatology’s New Access Landscape with Paul Rittman of Almirall US · February 19, 2026 · 23 min
• Functionally Speaking Series: Regulatory Intelligence, Medical Writing and the AI Inflection Point · January 30, 2026 · 37 min

Explore listener stats, chart rankings, contacts and more on the The Syneos Health Podcast podcast page.